KALGAE™ (Klebsormidium flaccidum var. ZIVO) dried algal biomass - 90-day dietary toxicity study and genotoxicity studies
Publication date: Available online 20 September 2018Source: Toxicology ReportsAuthor(s): Julie A. Brickel, Ray A. Matulka, Amy E. SteffekAbstractConsumers are demanding plant-based alternative protein sources to complement traditional animal-based protein sources to fulfill their dietary protein requirements. KALGAE™, a dried algal biomass derived from Klebsormidium flaccidum var. ZIVO, is a potential source of plant-based protein that has been evaluated for safety to support its use as a food ingredient. There were no treatment-related adverse effects observed in the 14-day palatability/toxicity or 90-day dietary toxicity study in CRL Sprague-Dawley CD® IGS rats. In the 90-day study, KALGAE™ was administered to rats in the diet at 0, 37,500, 75,000, or 150,000 ppm. No adverse effects were attributed to the test substance for the following parameters: body weight, body weight gain, mean food consumption and efficiency, hematology, clinical chemistry, urinalysis, gross pathology, histopathology, or organ weights. Although some statistically significant effects were recorded, the effects were not considered to be of toxicological relevance. A No Observable Adverse Effect Level (NOAEL) of 150,000 ppm, equivalent to dietary intakes of 7895.2 (male) and 9708.09 (female) mg KALGAE™/kg body weight/day in rats was established. KALGAE™ was non-mutagenic in the in vitro bacterial reverse mutation assay at concentrations up to 5000 µ...
ConclusionsPA activates PXR signalling and suppresses NF-κB signalling, consequently causing ameliorating inflammation. Results highlight the importance of PXR–NF-κB crosstalk in colitis and suggest a novel therapeutic reagent.Graphical abstract
ConclusionsThis study suggests that PLS exhibits anti-inflammatory action against intestinal damage by reducing inflammatory cell infiltration, oxidative stress, pro-inflammatory action of cytokines, and COX-2 expression in the inflamed colon. PLS shows therapeutic potential against inflammatory disorders like UC.Graphical abstract
ConclusionsThe findings indicate that combined traditional Thai herbal formulations can be used to successfully treat chronic eczema and could be considered as an alternative treatment for refractory chronic eczema.
ConclusionsFrailty assessment may be good value for money. However, limited availability of geriatric consultation services, may hinder implementation. Thus, the estimated benefits of frailty screening may not be achievable in practice.
We report the case of a 17-year-old patient with recurrent hemorrhagic pericardial effusion, who was diagnosed with primary pericardial fibrosarcoma. However, multiple radiological examinations, including CT and [18F] FDG/PET-CT, suggested the presence of fluid and no sign of tumor. Actually, when a patient presents with recurrent hemorrhagic pericardial effusions, pericardial tumors must be taken into account as part of the differential diagnosis.
We present two young patients (
Publication date: Available online 12 October 2019Source: Canadian Journal of CardiologyAuthor(s): Isabelle F. Vonder Muhll
We describe a contiguous gene deletion of the ATM locus in a multi-generation family of Italian descent with a strong family history of pancreatic cancer. A deletion of one copy of the entire ATM gene was identified by routine panel testing and further characterized by chromosomal microarray analysis. An 11q22.3 microdeletion of approximately 960kb was identified that is predicted to result in loss of 10 genes including ATM. The deletion was identified in two additional family members including a presymptomatic daughter and an affected sibling. A normal disomic complement of the 11q22.3 region was detected in a third famil...
Conclusions: The DC-TAV program is an ambitious, civilian-military, nationwide and long-term program, based on a harmonised standard of care and including multidimensional training. Further studies are required to assess its efficacy.
Publication date: Available online 12 October 2019Source: Anaesthesia Critical Care &Pain MedicineAuthor(s): Arnaud Chaumeron, Jeremie Castanie, Louis Philippe Fortier, Patrick Basset, Sophie Bastide, Sandrine Alonso, Jean-Yves Lefrant, Philippe CuvillonABSTRACTBackground: Rapid sequence induction (RSI) is recommended in patients at risk of aspiration, but induced hemodynamic adverse events, including tachycardia. In elderly patients, this trial aimed to assess the impact of the addition of remifentanil during RSI on the occurrence of: tachycardia (primary outcome), hypertension (due to intubation) nor hypotension (rem...